‘The Odyssey’ Becomes Christopher Nolan’s Biggest Global Debut of All Time With $264 Million

Get the Culture newsletter
Daily culture — film, music, books, the trends and ideas worth your attention. Free.
- 'The Odyssey' opened to $264.1 million globally ($139.6M international, $124.5M domestic), the biggest worldwide debut of Christopher Nolan's career, surpassing 2012's 'The Dark Knight Rises' ($249M) and 2009's 'The Dark Knight' ($198M).
- The film ranks as the third-biggest opening of the year, behind 'The Super Mario Galaxy Movie' ($372.5M) and 'Toy Story 5' ($312M), despite its R rating, nearly three-hour runtime, and lack of franchise ties.
- Nolan's adaptation of Homer's epic stars Matt Damon as Odysseus alongside Tom Holland, Anne Hathaway, Robert Pattinson, Lupita Nyong'o, Zendaya, Charlize Theron, Elliot Page, Jon Bernthal, and John Leguizamo, with reviews and word-of-mouth described as stellar.
- Top international markets were the UK and Ireland ($17.4M), France ($13.7M), and Italy ($11.5M); the film marked Nolan's biggest opening in 48 of 73 international territories and has yet to open in South Korea, China, or Japan.
- The Odyssey is the first feature shot entirely with Imax cameras, and the format contributed $51.8M globally (23% of opening revenues) — Imax's biggest opening in like-for-like markets, ahead of 'Avengers: Endgame.'
- Imax CEO Richard Gelfond called the weekend a 'transcendent moment' for the company, saying the film is currently pacing 47% ahead of 'Oppenheimer,' which opened to $35M in Imax worldwide.
- Universal distributed the film, which delivered the studio its largest debut in 11 international markets.
Why it matters: An R-rated, three-hour non-franchise film clearing $264M globally — and $51.8M of that in Imax alone — demonstrates premium-format demand is no longer limited to superhero IP, giving Imax and exhibitors leverage with premium pricing on adult-oriented originals. Pending releases in South Korea, China, and Japan could push the total even higher, while Nolan's hit continues to validate Universal's willingness to back long, auteur-driven spectacles.




